Literature DB >> 10482633

Altered virulence of vaccine strains of measles virus after prolonged replication in human tissue.

A Valsamakis1, P G Auwaerter, B K Rima, H Kaneshima, D E Griffin.   

Abstract

To understand the molecular determinants of measles virus (MV) virulence, we have used the SCID-hu thymus/liver xenograft model (SCID-hu thy/liv) in which in vivo MV virulence phenotypes are faithfully duplicated. Stromal epithelial and monocytic cells are infected by MV in thymus implants, and virulent strains induce massive thymocyte apoptosis, although thymocytes are not infected. To determine whether passage of an avirulent vaccine strain in human tissue increases virulence, we studied a virus isolated from thymic tissue 90 days after infection with the vaccine strain Moraten (pMor-1) and a virus isolated from an immunodeficient child with progressive vaccine-induced disease (Hu2). These viruses were compared to a minimally passaged wild-type Edmonston strain (Ed-wt) and the vaccine strain Moraten. pMor-1, Hu2, and Ed-wt displayed virulent phenotypes in thymic implants, with high levels of virus being detected by 3 days after infection (10(5.2), 10(2.8), and 10(3. 4), respectively) and maximal levels being detected between 7 and 14 days after infection. In contrast, Moraten required over 14 days to grow to detectable levels. pMor-1 produced the highest levels of virus throughout infection, suggesting thymic adaptation of this strain. Similar to other virulent strains, Ed-wt, Hu2, and pMor-1 caused a decrease in the number of viable thymocytes as assessed by trypan blue exclusion and fluorescence-activated cell sorter analysis. Thymic architecture was also disrupted by these strains. Sequence analysis of the hemagglutinin (H) and matrix (M) genes showed no common changes in Hu2 and pMor-1. M sequences were identical in pMor-1 and Mor and varied in H at amino acid 469 (threonine to alanine), a position near the base of propeller 4 in the propeller blade/stem model of H structure. Further study will provide insights into the determinants of virulence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482633      PMCID: PMC112900          DOI: 10.1128/JVI.73.10.8791-8797.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin.

Authors:  J P Langedijk; F J Daus; J T van Oirschot
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Experimental measles. I. Pathogenesis in the normal and the immunized host.

Authors:  M B McChesney; C J Miller; P A Rota; Y D Zhu; L Antipa; N W Lerche; R Ahmed; W J Bellini
Journal:  Virology       Date:  1997-06-23       Impact factor: 3.616

3.  Vaccine-associated measles pneumonitis in an adult with AIDS.

Authors:  J B Angel; P Walpita; R A Lerch; M S Sidhu; M Masurekar; R A DeLellis; J T Noble; D R Snydman; S A Udem
Journal:  Ann Intern Med       Date:  1998-07-15       Impact factor: 25.391

4.  Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes.

Authors:  M H Skiadopoulos; A P Durbin; J M Tatem; S L Wu; M Paschalis; T Tao; P L Collins; B R Murphy
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture.

Authors:  B K Rima; J A Earle; K Baczko; V ter Meulen; U G Liebert; C Carstens; J Carabaña; M Caballero; M L Celma; R Fernandez-Muñoz
Journal:  J Gen Virol       Date:  1997-01       Impact factor: 3.891

Review 6.  Monkeys in measles research.

Authors:  R S van Binnendijk; R W van der Heijden; A D Osterhaus
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

7.  A transgenic mouse model for measles virus infection of the brain.

Authors:  G F Rall; M Manchester; L R Daniels; E M Callahan; A R Belman; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells.

Authors:  E C Hsu; F Sarangi; C Iorio; M S Sidhu; S A Udem; D L Dillehay; W Xu; P A Rota; W J Bellini; C D Richardson
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis.

Authors:  P G Auwaerter; H Kaneshima; J M McCune; G Wiegand; D E Griffin
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Measles virus spread and pathogenesis in genetically modified mice.

Authors:  B Mrkic; J Pavlovic; T Rülicke; P Volpe; C J Buchholz; D Hourcade; J P Atkinson; A Aguzzi; R Cattaneo
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more
  10 in total

1.  CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition.

Authors:  C Erlenhoefer; W J Wurzer; S Löffler; S Schneider-Schaulies; V ter Meulen; J Schneider-Schaulies
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 2.  Measles Vaccine.

Authors:  Diane E Griffin
Journal:  Viral Immunol       Date:  2017-12-19       Impact factor: 2.257

Review 3.  Measles virus-induced immunosuppression: from effectors to mechanisms.

Authors:  Elita Avota; Evelyn Gassert; Sibylle Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-04-08       Impact factor: 3.402

4.  Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice.

Authors:  Weijia Wang; Shannon L Taylor; Stacey A Leisenfelder; Robert Morton; Jennifer F Moffat; Sergey Smirnov; Hua Zhu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  The double-edged sword: How evolution can make or break a live-attenuated virus vaccine.

Authors:  Kathryn A Hanley
Journal:  Evolution (N Y)       Date:  2011-12

6.  A chimeric human-bovine parainfluenza virus type 3 expressing measles virus hemagglutinin is attenuated for replication but is still immunogenic in rhesus monkeys.

Authors:  M H Skiadopoulos; S R Surman; J M Riggs; P L Collins; B R Murphy
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 7.  Humanized mouse models of epstein-barr virus infection and associated diseases.

Authors:  Shigeyoshi Fujiwara; Go Matsuda; Ken-Ichi Imadome
Journal:  Pathogens       Date:  2013-03-14

8.  Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.

Authors:  Nandadeva Lokugamage; Tetsuro Ikegami
Journal:  NPJ Vaccines       Date:  2017-07-17       Impact factor: 7.344

9.  A durable protective immune response to wild-type measles virus infection of macaques is due to viral replication and spread in lymphoid tissues.

Authors:  Wen-Hsuan W Lin; Eileen Moran; Robert J Adams; Robert E Sievers; Debra Hauer; Steven Godin; Diane E Griffin
Journal:  Sci Transl Med       Date:  2020-04-01       Impact factor: 17.956

Review 10.  Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.

Authors:  Aoife K O'Connell; Florian Douam
Journal:  Vaccines (Basel)       Date:  2020-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.